We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+12.42%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$450M
AUM Growth
+$22.2M
Cap. Flow
-$22.2M
Cap. Flow %
-4.93%
Top 10 Hldgs %
56.42%
Holding
36
New
3
Increased
16
Reduced
10
Closed
6

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$13.8M
2
MASI
Masimo
MASI
+$6.95M
3
RAD
Rite Aid Corporation
RAD
+$6.44M
4
BAX icon
Baxter International
BAX
+$5.89M
5
HSP
HOSPIRA INC
HSP
+$4.76M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$15M
2
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$13.3M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$10.3M
4
EW icon
Edwards Lifesciences
EW
+$9.17M
5
THOR
THORATEC CORPORATION
THOR
+$6.86M

Sector Composition

Rank Sector Weight
1 Healthcare 91.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAX icon
1
Baxter International
BAX
$11.7B
$43.5M 9.68%
1,093,370
+151,146
+16% +$5.89M
LLY icon
2
Eli Lilly
LLY
$1.05T
$37.8M 8.42%
548,447
-221,700
-29% -$15M
BSX icon
3
Boston Scientific
BSX
$65.4B
$35.7M 7.94%
2,692,600
+145,000
+6% +$1.85M
SYK icon
4
Stryker
SYK
$123B
$23.6M 5.24%
249,683
+39,500
+19% +$3.5M
BMY icon
5
Bristol-Myers Squibb
BMY
$124B
$22.7M 5.06%
385,200
+68,200
+22% +$3.85M
EW icon
6
Edwards Lifesciences
EW
$49.4B
$20.5M 4.57%
967,200
-456,600
-32% -$9.17M
RVTY icon
7
Revvity
RVTY
$12.3B
$18.8M 4.18%
429,760
+32,300
+8% +$1.39M
IRWD icon
8
Ironwood Pharmaceuticals
IRWD
$635M
$17.5M 3.9%
1,367,358
+8,239
+0.6% +$94.3K
HSP
9
DELISTED
HOSPIRA INC
HSP
$17.4M 3.87%
284,300
+84,300
+42% +$4.76M
LPNT
10
DELISTED
LifePoint Health, Inc.
LPNT
$16M 3.57%
222,900
+23,200
+12% +$1.61M
DGX icon
11
Quest Diagnostics
DGX
$23.3B
$15.7M 3.5%
234,628
-44,500
-16% -$2.81M
VTRS icon
12
Viatris
VTRS
$20.1B
$14.5M 3.22%
+256,600
New +$13.8M
CAH icon
13
Cardinal Health
CAH
$53.5B
$13.5M 2.99%
166,700
-33,300
-17% -$2.63M
THC icon
14
Tenet Healthcare
THC
$16.8B
$13M 2.9%
257,500
+28,000
+12% +$1.46M
THOR
15
DELISTED
THORATEC CORPORATION
THOR
$12.7M 2.83%
392,500
-235,800
-38% -$6.86M
VRTX icon
16
Vertex Pharmaceuticals
VRTX
$123B
$12.2M 2.71%
102,463
+28,000
+38% +$3.15M
BIO icon
17
Bio-Rad Laboratories Class A
BIO
$8.15B
$11.6M 2.58%
96,200
+19,100
+25% +$2.2M
PDCO
18
DELISTED
Patterson Companies, Inc.
PDCO
$11.4M 2.54%
237,465
-21,000
-8% -$946K
WCG
19
DELISTED
Wellcare Health Plans, Inc.
WCG
$11.1M 2.46%
134,745
-38,400
-22% -$2.68M
COR icon
20
Cencora
COR
$59.9B
$10.1M 2.26%
112,500
+14,500
+15% +$1.24M
CI icon
21
Cigna
CI
$74.5B
$9.67M 2.15%
94,000
+45,000
+92% +$4.43M
TEVA icon
22
Teva Pharmaceuticals
TEVA
$37.3B
$8.99M 2%
156,300
-184,300
-54% -$10.3M
IART icon
23
Integra LifeSciences
IART
$1.5B
$8.85M 1.97%
399,174
+119,809
+43% +$2.43M
RAD
24
DELISTED
Rite Aid Corporation
RAD
$8.73M 1.94%
+58,050
New +$6.44M
RMD icon
25
ResMed
RMD
$28.9B
$8.09M 1.8%
144,300
-87,000
-38% -$4.54M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2014 Portfolio in Review

As of Q4 2014, Sector Gamma AS held 36 positions worth $450M, up 5.2% from $427M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sector Gamma AS withdrew a net $22.2M in Q4 2014, closing 6 positions and reducing 10 holdings. Its most notable exit was CUBIST PHARMACEUTICALS INC, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 86% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Viatris worth $14.5M.

  • Sector Gamma AS's largest Q4 2014 buy was Viatris: 256,600 shares worth $14.5M.
  • Sector Gamma AS added most to Baxter International in Q4 2014, an estimated $5.89M increase.
  • Sector Gamma AS's biggest Q4 2014 reduction was Eli Lilly, cutting an estimated $15M.
  • Sector Gamma AS fully exited CUBIST PHARMACEUTICALS INC in Q4 2014, selling an estimated $13.3M.
  • Sector Gamma AS's ten largest holdings make up 56% of its $450M portfolio in Q4 2014.
  • Sector Gamma AS opened 3 new positions and closed 6 in Q4 2014.
  • Sector Gamma AS's portfolio value rose 5.2% quarter-over-quarter to $450M.

Based on Sector Gamma AS's 13F filing for Q4 2014, filed 17 Feb 2015.